Maury Raycroft (analyst) Hi everyone, my name is Maury Raycroft, and I am one of the biotech analysts at Jefferies. Thanks for joining us for our London conference. And I would like to welcome the … [Read more...] about BCRX Transcript: Jefferies London Conference 2021
BCRX
Gene Therapy Exciting, But Early
Gene therapy involves inserting genetic material into cells to prevent, cure, or correct a disease caused by genetic abnormalities whereas gene editing involves making actual changes to the genetic … [Read more...] about Gene Therapy Exciting, But Early
Investment Update: BCRX
Update 9/30/20 Today BCRX presented updated data for its ongoing Phase 1 proof of concept study for BCX9930 in treatment-naive PNH patients. Despite this impressive and unambiguous efficacy and safety … [Read more...] about Investment Update: BCRX
BCRX Updates
With BCRX there are a number of positive features that make it an attractive investment at its current valuation (near 5-year lows; on track to have its second commercial asset approved this year), … [Read more...] about BCRX Updates
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish
You must be logged in to post a comment.